STING1 and cancer: Here, the cGAMP-siPDL1@NPs and cGAMP-siPDL1@GalNPs efficiently activated the STING pathway and immune responses, and siPDL1 delivery down-regulated the expression of immunosuppressive PD-L1 in cancer cells and tumors.